Proteinases in cardiovascular aneurysms and rupture: targets for therapy?
Open Access
- 1 June 2000
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 105 (11) , 1519-1520
- https://doi.org/10.1172/jci10242
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysmsJournal of Clinical Investigation, 2000
- Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failureNature Medicine, 1999
- MMP Inhibition in Abdominal Aortic Aneurysms: Rationale for a Prospective Randomized Clinical TrialAnnals of the New York Academy of Sciences, 1999
- Prevention of Aneurysm Development and Rupture by Local Overexpression of Plasminogen Activator Inhibitor-1Circulation, 1998
- Postinfarction Ventricular Septal Rupture: The Wessex ExperienceSeminars in Thoracic and Cardiovascular Surgery, 1998
- Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formationNature Genetics, 1997
- CELL AND EXTRACELLULAR MATRIX REJECTION IN ARTERIAL CONCORDANT AND DISCORDANT XENOGRAFTS IN THE RAT1Transplantation, 1996
- Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problemCurrent Opinion in Cardiology, 1996
- Plasminogen Activator Expression in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Demonstration of Interstitial Collagenase in Abdominal Aortic Aneurysm DiseaseJournal of Surgical Research, 1993